BartelsK, GrenzA, and EltzschigHK. (2013). Hypoxia and inflammation are two sides of the same coin. Proc Natl Acad Sci USA, 110:18351–18352.
2.
BärtschP, and SwensonE. (2013). Acute high-altitude illnesses. New Engl J Med, 368:2294–2302.
3.
CogoA, and MiserocchiG. (2011). Pro: Most climbers develop subclinical pulmonary interstitial edema. High Alt Med Biol., 12:121–124.
4.
EngelhardtS, PatkarS, and OgunsholaOO. (2014). Cell-specific blood-brain barrier regulation in health and disease: A focus on hypoxia. Br J Pharmacol, 171:1210–1230.
5.
FischlerM, MaggioriniM, DorschnerL, DebrunnerJ, BernheimA, KienckeS, MairbäurlH, BlochKE, NaeijeR, and Brunner-La RoccaHP. (2009). Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema. Am J Respir Crit Care Med, 180:346–352.
6.
GüneyS, SchulerA, OttA, HöscheleS, ZügelS, BalogluE, BärtschP, and MairbäurlH. (2007). Dexamethasone prevents transport inhibition by hypoxia in rat lung and alveolar epithelial cells by stimulating activity and expression of Na+-K+-ATPase and epithelial Na+ channels. Am J Physiol Lung Cell Mol Physiol, 293:L1332–L1338.
7.
HackettPH, and RoachRC. (2001). High-altitude illness. N Engl J Med, 345:107–114
8.
HackettPH, RennieID, GroverRF, and ReevesJT. (1981). Acute mountain sickness and the edemas of high altitude: A common pathogenesis?. Respir Physiol, 46:383–390.
9.
HallED. (1992). Neuroprotective pharmacology of methyl-prednisolone. J Neurosurg, 76:13–22.
10.
HansenJM, OlsenN, Feldt-RasmussenB, KanstrupIL, DéchauxM, DubrayC, and RichaletJP. (1994). Albuminuria and overall capillary permeability of albumin in acute altitude hypoxia. J Appl Physiol, 76:1922–1927.
11.
KawashimaA, KuboK, MatsuzawaY, KobayashiT, and SekiguchiM. (1992). Hypoxia-induced ANP secretion in subjects susceptible to high-altitude pulmonary edema. Respir Physiol, 89:309–317.
12.
KimH, LeeJM, ParkJS, JoSA, KimY-O, KimC-W, and JoI. (2008). Dexamethasone coordinately regulates angiopoietin-1 and VEGF: A mechanism of glucocorticoid-induced stabilization of blood-brain barrier. Biochem Biophys Res Commun, 372:243–248.
LandisEM, JonasL, AngevineM, and ErbW. (1932). The passage of fluid and protein through the human capillary wall during venous congestion. J Clin Invest, 11:17–29.
15.
LevittJE, and MatthayMA. (2012). Clinical review: Early treatment of acute lung injury—Paradigm shift toward prevention and treatment prior to respiratory failure. Critical Care, 16:223.
16.
MaggioriniM, Brunner-La RoccaHP, PethS, FischlerM, BohmT, BernheimA, KienckeS, BlochKE, DehnertC, NaeijeR, LehmannT, BärtschP, and MairbäurlH. (2006). Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: A randomized trial. Ann Intern Med, 145:497–506.
17.
MairbäurlH. (2006). Role of alveolar epithelial sodium transport in high altitude pulmonary edema (HAPE). Respir Physiol Neurobiol, 151:178–191.
18.
MitznerW, and SylvesterJT. (1981). Hypoxic vasoconstriction and fluid filtration in pig lungs. J Appl Physiol, 51:1065–1071.
19.
MiserocchiG. (2007). Lung interstitial pressure and structure in acute hypoxia. Adv Exp Med Biol, 618:141–157.
20.
ModestiPA, VanniS, MorabitoM, ModestiA, MarchettaM, GamberiT, SofiF, SaviaG, ManciaG, GensiniGF, and ParatiG. (2006). Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) Study. Circulation, 114:1410–1416.
21.
MurataT, HoriM, SakamotoK, KarakiH, and OzakiH. (2004). Dexamethasone blocks hypoxia-induced endothelial dysfunction in organ-cultured pulmonary arteries. Am J Respir Crit Care Med, 170:647–655.
22.
OelzO, MaggioriniM, RitterM, WaberU, JenniR, VockP, and BartschP. (1989). Nifedipine for high altitude pulmonary edema. Lancet, 2:1241–1244.
23.
OgawaS, GerlachH, EspositoC, Pasagian-MacaulayA, BrettJ, and SternD. (1990). Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. J Clin Invest, 85:1090–1098.
24.
PerrettiM, and AhluwaliaA. (2000). The microcirculation and inflammation: Site of action for glucocorticoids. Microcirculation, 7:147–161.
25.
PhamI, WuerznerG, RichaletJP, PeyrardS, and AziziM. (2010). Endothelin receptors blockade blunts hypoxia-induced increase in PAP in humans. Eur J Clin Invest, 40:195–202.
26.
PlanèsC, EscoubetB, Blot-ChabaudM, FriedlanderG, FarmanN, and ClericiC. (1997). Hypoxia downregulates expression and activity of epithelial sodium channels in rat alveolar epithelial cells. Am J Respir Cell Mol Biol, 17:508–518.
27.
RichaletJP, RathatC, KéromèsA, HerryJP, LarmignatP, GarnierM, and PilardeauP. (1983). Plasma volume, body weight and acute mountain sickness. Lancet, 1:525.
28.
RichaletJP, HornychA, RathatC, AumontJ, LarmignatP, and RémyP. (1991). Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia. Respir Physiol, 85:205–215.
29.
RichaletJP. (1995). High-altitude pulmonary oedema. Still a place for controversy?. Thorax, 50:923–929.
30.
RichaletJP, and HerryJP. (2006). Médecine de l'Alpinisme et des Sports de Montagne. Masson, 4th ed., Paris, p. 134.
31.
RiusJ, GumaM, SchachtrupC, AkassoglouK, ZinkernagelAS, NizetV, JohnsonRS, HaddadGG, and KarinM. (2008). NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature, 453:807–811.
32.
SaradaS, HimadriP, MishraC, GeetaliP, RamMS, and IlavazhaganG. (2008). Role of oxidative stress and NFkB in hypoxia-induced pulmonary edema. Exp Biol Med (Maywood), 233:1088–1098.
33.
SchoeneRB, HackettPH, HendersonWR, SageEH, ChouM, RoachRC, MillsWJJr, and MartinTR. (1986). High altitude pulmonary edema. Characteristics of lung lavage fluid. JAMA, 256:63–69.
34.
SharmaM, SinghSB, and SarkarS. (2014). Genome wide expression analysis suggests perturbation of vascular homeostasis during high altitude pulmonary edema. PLoS One, 9:e85902.
35.
SiebenmannC, BlochKE, LundbyC, Nussbamer-OchsnerY, SchoebM, and MaggioriniM. (2011). Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559 m. High Alt Med Biol, 12:169–177.
36.
StelznerTJ, O'BrienRF, SatoK, and WeilJV. (1988). Hypoxia-induced increases in pulmonary transvascular protein escape in rats. Modulation by glucocorticoids. J Clin Invest, 82:1840–1847.
37.
SwensonER, MaggioriniM, MongovinS, GibbsJS, GreveI, MairbäurlH, and BärtschP. (2002). Pathogenesis of high-altitude pulmonary edema: Inflammation is not an etiologic factor. JAMA, 287:2228–2235. Erratum in: JAMA;288:1064.
38.
TorokB, RothE, ZsoldosT, TigyiA, MatkovicS, and SzaboL. (1986). Lipid peroxidation in lung of rats exposed to hyperoxic, hypoxic and ischemic effects. Exp Pathol, 29:221–226.
39.
van der VeldenVH. (1998). Glucocorticoids: Mechanisms of action and anti-inflammatory potential in asthma. Mediators Inflamm, 7:229–327.
40.
VoelkelNF. (1985). Review: Species variation in the pulmonary responses to arachidonic acid metabolites. Prostaglandins, 29:867–889.
41.
WeidmannP, HaslerL, GnädingerMP, LangRE, UehlingerDE, ShawS, RascherW, and ReubiFC. (1986). Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest, 77:734–742.
42.
YanSF, OgawaS, SternDM, and PinskyDJ. (1997). Hypoxia induced modulation of endothelial cell properties: Regulation of barrier-function and expression of interleukin-6. Kidney Int, 51:419–425.
